Phase 2 Study of GI-4000 Vaccine as Adjuvant Consolidation Therapy Following Resection of Patients With Stage I-III Adenocarcinoma of the Lung With G12C, G12D, and G12V KRAS Mutations
JOURNAL OF THORACIC ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要